Toward a dynamic model of deposition and utilization of yolk steroids.

The discovery by Schwabl that maternal steroid hormones are transferred to the egg yolk and have effects on the phenotype of offspring revealed a new pathway for non-genetic maternal effects. The initial model relied on passive transfer. The thinking was that steroids passively entered the lipophillic yolk during yolk deposition and then were deposited in the yolk until they were passively delivered to the embryo as the yolk was used. Subsequent studies revealed that the system is much more dynamic than that. Here, we explore questions about how dynamic the system really is and look at questions like: Is transfer of maternal steroids to the yolk passive or is it actively regulated? At what stages of the maternal reproductive cycle are steroids transferred? During reproduction, how dynamic are the levels of yolk steroids? Especially in the case of potentially deleterious steroids (e.g., androgens in female offspring; glucocorticoids), once deposited can they come out of the yolk over time? Can they be metabolized by the yolk or by the embryo? During incubation, how much do steroid levels in the yolk change? Can steroids diffuse from the yolk to the embryo prior to yolk utilization? Does the embryo contribute to yolk steroid levels as it develops? We believe that comprehensive answers to questions like these will eventually allow us to generate a much more accurate and complete model of the transfer and utilization of yolk steroids and that this model will be much more dynamic and active than the one initially proposed.

Corticosterone modulation of reproductive and immune systems trade-offs in female tree lizards: long-term corticosterone manipulations via injectable gelling material.

Physiological trade-offs arise because multiple processes compete for the same limiting resources. While competition for resources has been demonstrated between reproduction and immune function, the regulation of this competition remains unclear. Corticosterone (CORT) is a likely mediator due to its dual role in mobilizing energy stores throughout the body and regulating physiological responses to stressors. We manipulated CORT concentrations and resources in pre-reproductive and reproductive female tree lizards (Urosaurus ornatus) to test the hypothesis that CORT regulates the distribution of limiting resources between the reproductive and immune systems. To manipulate circulating concentrations of CORT we utilized a novel method of hormone implantation, in which a polymeric compound is mixed with hormone and injected in liquid form into the animal. After injection, the liquid quickly gels in situ forming a slow release hormone implant. This method of hormone delivery eliminated the need for substantial wounds to the animal or repeated handling required by other methods. In this study, the hormone-treated animals had plasma CORT concentrations comparable to high physiological concentrations. We found that CORT treatment suppressed immune function, but only when animals were energetically compromised. We assessed immune function by measuring the healing rate of a cutaneous biopsy. Healing was suppressed in all CORT-treated reproductive animals and in all CORT-treated animals (pre-reproductive and reproductive) undergoing food restriction, but CORT had no effect in ad libitum non-reproductive females. The context-dependent action of CORT renders its response adjustable to changing environmental conditions and may allow for the suppression of specific functions depending on resource availability.

Corticosterone stimulates hatching of late-term tree lizard embryos.

The regulation of hatching in oviparous animals is important for successful reproduction and survival, but is poorly understood. We unexpectedly found that RU-486, a progesterone and glucocorticoid antagonist, interferes with hatching of viable tree lizard (Urosaurus ornatus) embryos in a dose-dependent manner and hypothesized that embryonic glucocorticoids regulate hatching. To test this hypothesis, we treated eggs with corticosterone (CORT) or vehicle on Day 30 (85%) of incubation, left other eggs untreated, and observed relative hatch order and hatch time. In one study, the CORT egg hatched first in 9 of 11 clutches. In a second study, the CORT egg hatched first in 9 of 12 clutches, before vehicle-treated eggs in 10 of 12 clutches, and before untreated eggs in 7 of 9 clutches. On average, CORT eggs hatched 18.2 h before vehicle-treated eggs and 11.6 h before untreated eggs. Thus, CORT accelerates hatching of near-term embryos and RU-486 appears to block this effect. CORT may mobilize energy substrates that fuel hatching and/or accelerate lung development, and may provide a mechanism by which stressed embryos escape environmental stressors.

Characterization of atrazine-induced gonadal malformations in African clawed frogs (Xenopus laevis) and comparisons with effects of an androgen antagonist (cyproterone acetate) and exogenous estrogen (17beta-estradiol): Support for the demasculinization/feminization hypothesis.

Atrazine is a potent endocrine disruptor that both chemically castrates and feminizes male amphibians. It depletes androgens in adult frogs and reduces androgen-dependent growth of the larynx in developing male larvae. It also disrupts normal gonadal development and feminizes the gonads of developing males. Gonadal malformations induced by atrazine include hermaphrodites and males with multiple testes [single sex polygonadism (SSP)], and effects occur at concentrations as low as 0.1 ppb (microg/L). Here, we describe the frequencies at which these malformations occur and compare them with morphologies induced by the estrogen, 17beta-estradiol (E2) , and the antiandrogen cyproterone acetate, as a first step in testing the hypothesis that the effects of atrazine are a combination of demasculinization and feminization. The various forms of hermaphroditism did not occur in controls. Nonpigmented ovaries, which occurred at relatively high frequencies in atrazine-treated larvae, were found in four individuals out of more than 400 controls examined (1%). Further, we show that several types of gonadal malformations (SSP and three forms of hermaphroditism) are produced by E2 exposure during gonadal differentiation, whereas a final morphology (nonpigmented ovaries) appears to be the result of chemical castration (disruption of androgen synthesis and/or activity) by atrazine. These experimental findings suggest that atrazine-induced gonadal malformations result from the depletion of androgens and production of estrogens, perhaps subsequent to the induction of aromatase by atrazine, a mechanism established in fish, amphibians, reptiles, and mammals (rodents and humans).